CORONAVIRUS/Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal
02/02/2024 09:53 PM
A COVID-19 vaccine research from Taiwan-based Medigen Vaccine Biologics Corp., which found its locally-produced vaccine was as effective as the Moderna and Pfizer BioNTech vaccines, will be featured in a United States medical publication.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan to shorten COVID-19 vaccine interval to 2 months for high-risk groupsThe Centers for Disease Control (CDC) announced Thursday that the required interval between two COVID-19 vaccine doses for high-risk groups will be shortened from six months to two months, effective next Wednesday.06/06/2025 08:17 PM
- CDC confirms ample supply of COVID-19 drugs, vaccinesThe Centers for Disease Control (CDC) reiterated Sunday that Taiwan has sufficient antiviral medication for COVID-19 patients and emphasized the importance of vaccination, amid concerns raised by public figures.06/01/2025 06:13 PM
- CDC issues COVID-19 warning as Dragon Boat Festival long weekend beginsMembers of the public should not let their guard down on COVID-19 and seek medical help if they experience symptoms that indicate risk of severe infection, the Centers for Disease Control (CDC) said Friday, the first day of the Dragon Boat Festival long weekend in Taiwan.05/30/2025 05:04 PM
Latest
- Culture
Academia Sinica eyes Ph.D applicants amid U.S. uncertainty
06/14/2025 09:08 PM - Society
Taiwan's organ transplants show growth in quantity and quality
06/14/2025 09:00 PM - Business
Taiwan ranks as 6th largest global net creditor in 2024
06/14/2025 07:12 PM - Business
Taiwan's economy set to grow 2.90% in 2025: Think tank
06/14/2025 07:02 PM - Sports
Jeremy Lin named 2024-25 TPBL regular season MVP
06/14/2025 06:41 PM